Contact
Please use this form to send email to PR contact of this press release:
FDA approves Admelog, the first short-acting "follow-on" insulin product to treat diabetes
TO:
Please use this form to send email to PR contact of this press release:
FDA approves Admelog, the first short-acting "follow-on" insulin product to treat diabetes
TO: